215 results on '"Sethi, Sanjum S."'
Search Results
2. Percutaneous Mechanical Aspiration in Infective Endocarditis: Applications, Technical Considerations, and Future Directions
3. Surgical and Endovascular Therapies for Below-the-Knee Peripheral Arterial Disease: A Contemporary Review
4. Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions
5. Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism
6. Validating the Composite Pulmonary Embolism Shock Score for Predicting Normotensive Shock in Intermediate-Risk Pulmonary Embolism
7. Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism
8. Prospective, Multicenter Registry to Assess Safety and Efficacy of Radial Access for Peripheral Artery Interventions
9. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
10. Gender Disparities in Presentation, Management, and Outcomes of Acute Pulmonary Embolism
11. Association of Modified Body Mass Index With In-Hospital Outcomes After Intermediate or High-Risk Pulmonary Embolism
12. Call for Formalized Pathways in Vascular Medicine Training: JACC Review Topic of the Week
13. Renal Artery Stenosis: State of the Art in the Diagnosis and Management
14. Advanced Therapies for Acute Pulmonary Embolism: A Focus on Catheter-Based Therapies and Future Directions
15. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19
16. Patient‐Reported Outcomes in Venous Thromboembolism: A Systematic Review of the Literature, Current Challenges, and Ways Forward
17. Percutaneous Transluminal Angioplasty for Infrapopliteal Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-analysis of Primary Patency and Binary Restenosis Rates
18. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
19. Risk Stratification of Acute Pulmonary Embolism
20. Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis
21. Association between Hispanic or Latino ethnicity and pulmonary embolism severity, management, and in-hospital outcomes
22. Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial
23. INTRAOPERATIVE MASSIVE PULMONARY EMBOLISM REQUIRING EMERGENT CATHETER THROMBECTOMY
24. VASCULAR EHLERS DANLOS SYNDROME - EASY TO MISS, HARD TO TREAT!
25. SEX DIFFERENCES IN PRESENTATION, MANAGEMENT AND OUTCOMES OF ACUTE PULMONARY EMBOLISM
26. LONG-TERM CHANGES IN RIGHT VENTRICULAR SIZE AND FUNCTION STRATIFIED BY TREATMENT MODALITY IN INTERMEDIATE AND HIGH-RISK PULMONARY EMBOLISM PATIENTS
27. ETHNIC DISPARITIES IN PULMONARY EMBOLISM SEVERITY, TREATMENT MODALITY, AND IN-HOSPITAL OUTCOMES
28. Diabetes and Coronary Artery Disease
29. Novel Scaffolds for the Treatment of Below-the-Knee Peripheral Arterial Disease With Chronic Limb Threatening Ischemia: A Review
30. The “Lollipop” During Catheter-Directed Thrombectomy
31. sj-pdf-1-vmj-10.1177_1358863X231157441 – Supplemental material for Association between Hispanic or Latino ethnicity and pulmonary embolism severity, management, and in-hospital outcomes
32. Preclose Cinching “C-Stitch” to Aid Hemostasis After Impella Insertion
33. 13 - Vascular access for noncardiac procedures
34. Iliac Venous Stent Embolization to the Right Atrium and Subsequent Extraction With in Vivo Recrimping
35. Leave No Stent Behind: Are Drug-Coated Balloons Enough for Femoropopliteal Disease?
36. Abstract 19431: Cardiovascular Disease Mortality Patterns Among Asian Indians by Nativity Status in the United States, 2003-2012
37. Safety of orbital atherectomy in patients with left ventricular systolic dysfunction
38. CLEARED SARS-COV-2 INFECTION IS ASSOCIATED WITH LOWER RISK PULMONARY EMBOLISM
39. IVUS AS AN ADJUNCT TO DIGITAL SUBTRACTION ANGIOGRAPHY IN THE TREATMENT OF INFLOW PERIPHERAL ARTERIAL DISEASE: EFFECT ON LUMEN GAIN
40. HIGHER MODIFIED BODY MASS INDEX IS ASSOCIATED WITH DECREASED MORTALITY AND BLEEDING AFTER TREATMENT FOR SEVERE PE
41. Biomarkers After Risk Stratification in Acute Chest Pain (from the BRIC Study)
42. Sex Differences in Peripheral Artery Disease
43. Abstract 17133: Complete Inferior Vena Cava Thrombosis In A Sickle Cell Patient With Suspected May Thurner Syndrome
44. Improving risk stratification in acute pulmonary embolism: How do we target our therapies more effectively?
45. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
46. Pulmonary Embolism Response Team utilization during the COVID-19 pandemic
47. Iatrogenic Arteriovenous Fistula Following Femoral Access Precipitating High-Output Heart Failure
48. Periprocedural Myocardial Enzyme Elevation: Prognostic Implications for Current Practice
49. Diabetes Mellitus and Acute Coronary Syndrome: Lessons From Randomized Clinical Trials
50. Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.